Inside the futuristic biotech startup Cellares that’s building a cure for cancer with $355 million in funding

Quick Summary:

Why New Jersey is a hub for biotech manufacturing.

Eclipse’s Justin Butler joined me on the tour of Cellares’ Bridgewater facility, which is currently being built with the aim of operating at clinical scale in about a year and commercial scale in two years.

A few weeks ago, I drove out to Bridgewater, N.J., and visited an unassuming office park where one such company, Cellares, is building sci-fi technology to cure blood cancer.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Leo Schwartz

Category: EconomyBusiness

Markets: United States

Topics: Startups Private equity Venture Capital Term Sheet

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-03-24 @ 11:00:56 (2 days ago)

News Timezone: GMT +8:00

News Source URL: fortune.com

Language: English

Article Length: 910 words

Reading Time: 6 minutes read

Sentences: 4 lines

Sentence Length: 228 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Fortune

News ID: 27274000

View Article Analysis

About Fortune

Main Topics: EconomyBusiness

Official Website: fortune.com

Update Frequency: 20 posts per day

Year Established: 1929

Headquarters: United States

News Last Updated: 8 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #95

Publisher Details

Frequently Asked Questions